The Experience of Testing for Coronavirus Disease (COVID-19) at a Single Diagnostic Center in Paraguay before the Introduction of Vaccination.
COVID-19 laboratory
Paraguay
low- and middle-income countries
pandemic preparedness
research
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
10 05 2023
10 05 2023
Historique:
received:
10
04
2023
revised:
02
05
2023
accepted:
06
05
2023
medline:
29
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
Soon after the declaration of the COVID-19 pandemic, the Institute for Health Sciences Research (IICS) of the National University of Asunción, Paraguay became a testing laboratory (COVID-Lab) for SARS-CoV-2. The COVID-Lab testing performance was assessed from 1 April 2020 to 12 May 2021. The effect of the pandemic on the IICS and how the COVID-Lab contributed to the academic and research activities of the institute were also assessed. IICS researchers and staff adjusted their work schedules to support the COVID-Lab. Of the 13,082 nasopharyngeal/oropharyngeal swabs processed, 2704 (20.7%) tested positive for SARS-CoV-2 by RT-PCR. Of the individuals testing positive, 55.4% were female and 48.3% were aged 21-40 years. Challenges faced by the COVID-Lab were unstable reagent access and insufficient staff; shifting obligations regarding research, academic instruction, and grantsmanship; and the continuous demands from the public for information on COVID-19. The IICS provided essential testing and reported on the progress of the pandemic. IICS researchers gained better laboratory equipment and expertise in molecular SARS-CoV-2 testing but struggled to manage their conflicting educational and additional research obligations during the pandemic, which affected their productivity. Therefore, policies protecting the time and resources of the faculty and staff engaged in pandemic-related work or research are necessary components of healthcare emergency preparedness.
Identifiants
pubmed: 37243222
pii: v15051136
doi: 10.3390/v15051136
pmc: PMC10220564
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
Nat Rev Microbiol. 2021 Mar;19(3):171-183
pubmed: 33057203
Sci Rep. 2020 Oct 6;10(1):16608
pubmed: 33024174
J Clin Virol Plus. 2021 Jun;1(1):100011
pubmed: 35261999
Nat Med. 2023 Feb;29(2):334-343
pubmed: 36797482
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):307-312
pubmed: 32556781
Ann Glob Health. 2021 Feb 25;87(1):23
pubmed: 33665145
JAMA. 2020 Jun 9;323(22):2249-2251
pubmed: 32374370
BMJ. 2020 Sep 18;370:m3575
pubmed: 32948599
Viruses. 2022 Apr 22;14(5):
pubmed: 35632615
Lancet Reg Health West Pac. 2022 Jan;18:100321
pubmed: 34841379
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705
pubmed: 33760236
Crit Rev Clin Lab Sci. 2021 Aug;58(5):297-310
pubmed: 33347790
PLoS One. 2021 Jun 29;16(6):e0253334
pubmed: 34185777
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet Reg Health Am. 2021 Dec;4:100086
pubmed: 34664040
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33277297
BMJ Open. 2022 Feb 2;12(2):e053374
pubmed: 35110318
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Lancet Glob Health. 2021 Jun;9(6):e782-e792
pubmed: 33857500